The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EORTC 26101 phase III trial exploring the combination of bevacizumab and lomustine in patients with first progression of a glioblastoma.
 
Wolfgang Wick
Honoraria - MSD Oncology; Prime Oncology; Roche/Genentech
Consulting or Advisory Role - Celldex; Roche/Genentech
Research Funding - Apogenix (Inst); Boehringer Ingelheim (Inst); Roche (Inst)
 
Alba Ariela Brandes
Travel, Accommodations, Expenses - Roche/Genentech
 
Thierry Gorlia
No Relationships to Disclose
 
Martin Bendszus
No Relationships to Disclose
 
Felix Sahm
No Relationships to Disclose
 
Walter Taal
No Relationships to Disclose
 
Martin J.B. Taphoorn
No Relationships to Disclose
 
Julien Domont
No Relationships to Disclose
 
Ahmed Idbaih
No Relationships to Disclose
 
Mario Campone
Honoraria - Menarini; Novartis; Servier
Consulting or Advisory Role - Menarini; Novartis; SERVIER
Speakers' Bureau - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Paul M. Clement
Research Funding - MSD (Inst)
Expert Testimony - Merck
 
Roger Stupp
Employment - Celgene (I)
Stock and Other Ownership Interests - Celgene (I)
Consulting or Advisory Role - Celgene (Inst); Debiopharm Group (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); UCB (Inst)
Travel, Accommodations, Expenses - Novocure
 
Michel Fabbro
Travel, Accommodations, Expenses - Roche
 
Emilie Le Rhun
Research Funding - Amgen (Inst); Mundipharma (Inst)
Travel, Accommodations, Expenses - Mundipharma
 
François Dubois
No Relationships to Disclose
 
Martin Klein
No Relationships to Disclose
 
Michael Platten
Honoraria - Merck Serono; Novartis; Roche/Genentech
Consulting or Advisory Role - Alexion Pharmaceuticals; Novartis; Roche/Genentech
Research Funding - Bayer Schering Pharma (Inst)
 
Michael Weller
Consulting or Advisory Role - Celldex; Isarna Therapeutics; Magforce; Merck KGaA (I); Merck Serono; Northwest Biotherapeutics; Novartis; Novocure; Pfizer; Roche/Genentech; Teva
Research Funding - Acceleron Pharma (Inst); Actelion (Inst); Bayer (Inst); Isarna Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Novocure (Inst); Pique (Inst)
 
Vassilis Golfinopoulos
No Relationships to Disclose
 
Martin J. Van Den Bent
Consulting or Advisory Role - Abbvie; Actelion; Amgen; Blue Earth Diagnostics; Bristol-Myers Squibb; Cavion; Celldex; Merck; Novartis; Novocure; Roche
Research Funding - Abbvie (Inst); Roche (Inst)